US Patent Issued to Celanese EVA Performance Polymers on Nov. 18 for "Implantable device for sustained release of a macromolecular drug compound" (American, Canadian, German Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,148, issued on Nov. 18, was assigned to Celanese EVA Performance Polymers LLC (Irving, Texas).

"Implantable device for sustained release of a macromolecular drug compound" was invented by Christian Schneider (Hattersheim, Germany), Jeffrey C. Haley (Norwood, Ohio), Dirk Hair (Edmonton, Canada), Harsh Patel (Union, Ky.) and Vijay Gyanani (Powell, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "An implantable device for delivery of a macromolecular drug compound is provided. The device comprises a core having an outer surface and a membrane layer positioned adjacent to the outer surface of the core. The core comprises a core polymer matrix within ...